The official journal of the BSTP is Toxicologic Pathology
As a subscriber, you will receive access to 8 issues a year and you will be issued with a membership number and will be able to view and search issues back to 1999.
For those who want to subscribe to the journal through the BSTP, there are two methods of subscription:
Print and online access which will cost £100 in addition to the membership fee i.e. £60 + £100 = £160
or
You can subscribe to the journal with online access only at a cost of £55 in addition to the membership fee i.e. £60 + £55 = £115
Existing STP members will receive their copy though the STP as usual.
To receive Toxicologic Pathology you need to tick the relevant box on the membership application or renewal form so that the subscription fee due can be adjusted accordingly. Please note that subscription will be valid for 1 year and no refunds are available if you cancel midterm.
Please note that, if you opt to receive Toxicologic Pathology, your contact details will be passed to the STP who will pass them to the publishers of the journal. Details of each issue will be sent to you direct from the publishers. Your positive response will indicate your permission for the Secretariat to release your contact details to these third parties.
BSTP - Call for Papers for the next special issue of Toxicologic Pathology Journal
Toxicologic Pathology is pleased to announce the publication of a special 2020 issue focusing on The Challenges of Inhaled Biotherapeutics. This peer-reviewed issue will bring together experts in the field of inhalation toxicology and pathology to provide an overview of the commonly encountered challenges associated with inhaled biologics. This issue will be forwarded by two white papers–the first addressing the pathological effects commonly seen with inhaled biologics and their implications for drug development, and the second addressing the toxicological and technical challenges associated with this route of delivery.
This call for papers seeks manuscripts from authors with experience in inhalation toxicology or the nonclinical development of inhaled biologics.
The_challenges_of_inhaled_biotherapeutics_-_Call_for_Papers.pdf (257.9 KiB, 40 hits)
BSTP - Call for Papers for the next special issue of Toxicologic Pathology Journal
Toxicologic Pathology is pleased to announce the publication of a special 2020 issue focusing on Stem Cell-based Therapy Development. Rapid advances in stem cell biology have produced confusion and misinformation on the readiness of this field for clinical use in humans and animals. This peer reviewed special issue will emphasize the issues concerning cell therapies, exemplified but not limited to stem cell and related fields. Major focus will be safety assessment, issues complicating nonclinical development of stem cell therapies, including study design, methods for evaluating histopathology findings, carcinogenicity evaluation, immune compatibility, and solutions to these issues to propel the field into the future therapies. This issue will explore concepts such as the fate of injected stem cells, teratoma formation and neoplasia, ectopic growths, use of autologous induced stem cells, use of stem cells in veterinary medicine and present state of the field. Also included will be issues of terminology and standardization of methods and nomenclature.
Stem_Cell_Issue_Call_for_Papers.pdf (246.4 KiB, 51 hits)
The journal Toxicologic Pathology has recently introduced a new category of mini review that is in addition to the review, invited review and original article categories. These succinct manuscripts should have the same structure as full length original review articles, but in much shorter form, and the section headings will be used only for the abstract, acknowledgements, and references.
Mini Review Category for Toxicologic Pathology (778.3 KiB, 221 hits)
Rules for authors and instructions for manuscript submission can be found here.
Submit your manuscript today:
www.uk.sagepub.com/journals/01926233/manuscriptSubmission
Toxicologic Pathology is dedicated to the promotion of human health through the dissemination of knowledge, techniques, and guidelines to enhance the understanding and practice of toxicologic pathology. The journal publishes timely high-quality, original research articles that integrate the pathophysiologic effects of exposure to xenobiotics and other toxicants on organisms and organ systems. Articles include both pathology and toxicology and focus on morphological, functional, biochemical, and/or biomarker changes to better understand the pathophysiologic mechanisms of toxicants in vivo and in vitro.
Average time from submission to first decision: 33 days Among the topics in recent issues are
•Adverse Events
•Angiogenesis Inhibitors
•Basic and Translational Research
•Drug Development for Pediatric Populations
•Drug-Induced Hematologic Toxicity
•Epigenetics
•Genomic Analyses
•Global Regulatory Perspectives
•Hazard Identification
•High Throughput Pathology
•Immunomodulation
•International Accreditation For Toxicologic Pathologists
•Lesions
•Neoplasia and Hyperplasia
•Risk Assessment
•Risk Communication
•Safety Assessments
•Tumor Pathology
•Use of Animal Models
Toxicologic Pathology also publishes timely in-depth current topic review papers, symposia papers, brief communications, best practice articles for scientific and regulatory processes, position papers on current regulatory issues, and fast-track articles.
This journal is a member of the Committee on Publication Ethics (COPE).
